Breaking the Throughput Barrier: Ultra-Large Virtual Screening as a Precision Amplifier for AI-Driven Drug Discovery

• Move towards out-of-domain chemistry by using models that generalize beyond the data we already have, enabling discovery in unexplored regions of biology an chemistry
• Generate novel chemistry and move beyond rediscovery of known scaffolds by investing in platforms that can generate truly new chemical matter
• Expand throughput and explore the full depth of chemical diversity where transformative, next generation drugs reside

Speakers:

Daniel Haders

Chief Executive Officer

Model Medicines